ClinicalTrials HQ

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

Recruiting · NCT06447025 · Registry updated 2026-10-09
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Open-Label Study of CTI-1601 in Subjects With Friedreich's AtaxiaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Friedreich ataxia, Nutritional and Metabolic Diseases, Spinocerebellar Degenerations, brain disorder, central nervous system disorder, cerebellar disorder, hereditary disease, inborn mitochondrial metabolism disorder, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, spinal cord disorderRecruitingPhase 22026-10-09NCT06447025

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Larimar Therapeutics, Inc.2

11 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Children's Hospital of PhiladelphiaPhiladelphiaUnited States434
Clinilabs Drug Development, Corp.EatontownUnited States1
Fixel Institute for Neurological Disease, University of Florida HealthGainesvilleUnited States1
ICONSalt Lake CityUnited States6
Morsani Center for Advanced Health Care, University of South Florida HealthTampaUnited States2
Ohio State University Wexner Medical CenterColumbusUnited States36
Uncommon CuresChevy ChaseUnited States5
University of California Los AngelesLos AngelesUnited States87
University of California, San Franciso Medical CenterSan FranciscoUnited States1
University of Iowa Hospitals & ClinicsIowa CityUnited States31
University of WashingtonSeattleUnited States172